Merger Update
17 May 2006 - 9:00PM
UK Regulatory
RNS Number:1062D
Office of Fair Trading
17 May 2006
INVITATION TO COMMENT
ANTICIPATED ACQUISITION BY ASTRAZENECA UK LIMITED OF CAMBRIDGE ANTIBODY
TECHNOLOGY PLC
The Office of Fair Trading is considering whether arrangements are in progress
or in contemplation which, if carried into effect, will result in the creation
of a relevant merger situation under the merger provisions of the Enterprise Act
2002. Should it be found to be a relevant merger situation, the OFT will
further consider whether the creation of that situation may be expected to
result in a substantial lessening of competition within any market or markets in
the United Kingdom for goods or services that warrants reference to the
Competition Commission for investigation and report.
Affected Sector: Biopharmaceuticals.
Please send written representations about any competition or public interest
issues to:
Mr Steven Clarke
Office of Fair Trading
Fleetbank House
2-6 Salisbury Square
London EC4Y 8JX
Email: Steven.Clarke@oft.gsi.gov.uk
FAX: 020-7211-8916
to arrive by 30 May 2006.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MERSFISUWSMSELI
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024